Showing results (211-220 of 332) with videos related to
Sort By:
Pageof 34
Inflammatory Bowel Diseases|May 9, 2026
Soluble transferrin receptor as a reliable inflammation-independent marker of iron deficiency in Crohn's disease and ulcerative colitisFrancisco Portela, Paula Ministro, Helena Tavares de Sousa, et al.Experimental Animals|February 4, 2021
2,4,6-trinitrobenzenesulfonic acid-induced colitis in Rattus norgevicus: a categorization proposalMariana Ferreira-Duarte, Tiago Rodrigues-Pinto, Daniela Menezes-Pinto, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2021
Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel diseasePaula Sousa, Paula Ministro, Alessandro Armuzzi, et al.Human Molecular Genetics|October 4, 2017
The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytesVera Lemos, Rita M de Oliveira, Luana Naia, et al.Therapeutic Advances in Gastroenterology|October 8, 2025
Adalimumab around the world: comparative analysis of products characteristics and patient support systemsTsz Hong Yiu, Emilia Anderson, Wai Keung Leung, et al.Advances in Therapy|January 6, 2022
Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 EraStefan Schreiber, Shomron Ben-Horin, Rieke Alten, et al.Acta Medica Portuguesa|May 29, 2016
[Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease]Fernando Magro, Jaime Ramos, Luís Correia, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2019
Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus groupFerdinando D'Amico, Lieven Pouillon, Marjorie Argollo, et al.Journal of Clinical Medicine|February 11, 2023
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative ColitisFerdinando D'Amico, Fernando Magro, Benedicte Caron, et al.Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.Pageof 34